Baughman, R. P., M. Judson, D. Culver, S. Birring, J. Parambil, J. Zeigler, and E. E. Lower. “Roflumilast (Daliresp®) to Reduce Acute Pulmonary Events in Fibrotic Sarcoidosis: A Multi-Center, Double Blind, Placebo Controlled, Randomized Clinical Trial”. Sarcoidosis, Vasculitis and Diffuse Lung Disease, vol. 38, no. 3, Sept. 2021, p. e2021035, doi:10.36141/svdld.v38i3.11684.